We break down Medicare’s brand-new GLP-1 Bridge Program and explain why headlines are both true and incomplete. We lay out the real eligibility rules, the $50 copay promise, and the smarter questions to ask so you and your clinician can find the right coverage pathway.
• why Medicare historically excludes weight loss medications and what changed with modern obesity medicine • what the GLP-1 Bridge Program is designed to do and why it is not universal coverage • the $50 copay detail and why office visits labs and deductibles can still affect total cost • who does not qualify because another Medicare Part D pathway may already apply • the three eligibility “doors” based on BMI and specific risk conditions • which GLP-1 medications are included at the time of recording and the planned program timeline • how to prepare for an appointment and the exact phrasing that helps your clinician pick the right route • why checking CMS and staying current matters as rules evolve
You can send us an email, you can find us on Threads, follow us on Instagram, or leave us some fan mail.
Podden och tillhörande omslagsbild på den här sidan tillhör
Ed Delesky, MD and Nicole Aruffo, RN. Innehållet i podden är skapat av Ed Delesky, MD and Nicole Aruffo, RN och inte av,
eller tillsammans med, Poddtoppen.